Smith & Nephew (SNN) Competitors $27.90 -0.24 (-0.84%) Closing price 04/3/2025 03:59 PM EasternExtended Trading$27.25 -0.65 (-2.31%) As of 09:09 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SNN vs. GEHC, PHG, ZBH, SOLV, PEN, STVN, GKOS, BLCO, INSP, and NARIShould you be buying Smith & Nephew stock or one of its competitors? The main competitors of Smith & Nephew include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), and Inari Medical (NARI). These companies are all part of the "medical equipment" industry. Smith & Nephew vs. GE HealthCare Technologies Koninklijke Philips Zimmer Biomet Solventum Penumbra Stevanato Group Glaukos Bausch + Lomb Inspire Medical Systems Inari Medical Smith & Nephew (NYSE:SNN) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, community ranking, valuation, dividends, institutional ownership, profitability, analyst recommendations and media sentiment. Does the MarketBeat Community favor SNN or GEHC? Smith & Nephew received 423 more outperform votes than GE HealthCare Technologies when rated by MarketBeat users. However, 61.90% of users gave GE HealthCare Technologies an outperform vote while only 54.29% of users gave Smith & Nephew an outperform vote. CompanyUnderperformOutperformSmith & NephewOutperform Votes44954.29% Underperform Votes37845.71% GE HealthCare TechnologiesOutperform Votes2661.90% Underperform Votes1638.10% Which has higher earnings and valuation, SNN or GEHC? GE HealthCare Technologies has higher revenue and earnings than Smith & Nephew. Smith & Nephew is trading at a lower price-to-earnings ratio than GE HealthCare Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSmith & Nephew$5.81B2.10$263M$2.1612.91GE HealthCare Technologies$19.67B1.67$1.99B$4.3316.63 Do analysts recommend SNN or GEHC? Smith & Nephew currently has a consensus target price of $27.00, suggesting a potential downside of 3.21%. GE HealthCare Technologies has a consensus target price of $97.73, suggesting a potential upside of 35.73%. Given GE HealthCare Technologies' stronger consensus rating and higher possible upside, analysts plainly believe GE HealthCare Technologies is more favorable than Smith & Nephew.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Smith & Nephew 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00GE HealthCare Technologies 1 Sell rating(s) 2 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.75 Does the media favor SNN or GEHC? In the previous week, GE HealthCare Technologies had 31 more articles in the media than Smith & Nephew. MarketBeat recorded 35 mentions for GE HealthCare Technologies and 4 mentions for Smith & Nephew. Smith & Nephew's average media sentiment score of 1.72 beat GE HealthCare Technologies' score of 1.18 indicating that Smith & Nephew is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Smith & Nephew 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive GE HealthCare Technologies 26 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals believe in SNN or GEHC? 25.6% of Smith & Nephew shares are owned by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 1.0% of Smith & Nephew shares are owned by company insiders. Comparatively, 0.3% of GE HealthCare Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is SNN or GEHC more profitable? GE HealthCare Technologies has a net margin of 10.13% compared to Smith & Nephew's net margin of 0.00%. GE HealthCare Technologies' return on equity of 25.74% beat Smith & Nephew's return on equity.Company Net Margins Return on Equity Return on Assets Smith & NephewN/A N/A N/A GE HealthCare Technologies 10.13%25.74%6.29% Which has more volatility and risk, SNN or GEHC? Smith & Nephew has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500. Comparatively, GE HealthCare Technologies has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500. Is SNN or GEHC a better dividend stock? Smith & Nephew pays an annual dividend of $0.89 per share and has a dividend yield of 3.2%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Smith & Nephew pays out 41.2% of its earnings in the form of a dividend. GE HealthCare Technologies pays out 3.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. SummaryGE HealthCare Technologies beats Smith & Nephew on 16 of the 21 factors compared between the two stocks. Remove Ads Get Smith & Nephew News Delivered to You Automatically Sign up to receive the latest news and ratings for SNN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNN vs. The Competition Export to ExcelMetricSmith & NephewSurgical appliances & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$12.22B$8.86B$5.53B$18.94BDividend Yield3.17%1.42%4.86%3.78%P/E Ratio12.9118.9423.2331.59Price / Sales2.1071.93362.7525.45Price / Cash8.0019.6738.1617.54Price / Book2.344.946.494.36Net Income$263M$284.66M$3.21B$1.02B7 Day Performance-0.46%-4.87%-4.90%-3.87%1 Month Performance-6.94%-7.95%-0.07%-4.82%1 Year Performance14.61%-23.19%6.45%0.29% Smith & Nephew Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNNSmith & Nephew2.928 of 5 stars$27.90-0.8%$27.00-3.2%+13.3%$12.22B$5.81B12.9120,100GEHCGE HealthCare Technologies4.102 of 5 stars$80.71+0.9%$98.75+22.4%-19.1%$36.91B$19.67B18.6450,000Positive NewsGap DownPHGKoninklijke Philips3.6227 of 5 stars$25.40-1.0%N/A+16.7%$23.87B$18.02B-30.2378,200ZBHZimmer Biomet4.6871 of 5 stars$113.33+1.2%$124.15+9.5%-13.3%$22.56B$7.68B25.4718,000Positive NewsSOLVSolventum1.4129 of 5 stars$76.02+1.7%$79.86+5.0%+10.2%$13.15B$8.25B27.6422,000Gap DownPENPenumbra4.3282 of 5 stars$267.84+0.1%$294.47+9.9%+26.8%$10.32B$1.19B787.773,900Insider TradeAnalyst RevisionNews CoverageGap DownSTVNStevanato Group1.6672 of 5 stars€20.37+0.4%N/A-32.6%$6.17B$1.10B43.344,650Positive NewsGKOSGlaukos3.9413 of 5 stars$98.49-3.4%$163.25+65.8%-7.9%$5.57B$383.48M-34.32780News CoveragePositive NewsGap DownBLCOBausch + Lomb3.7937 of 5 stars$14.50+2.6%$19.18+32.3%-21.4%$5.11B$4.79B-15.9312,500Analyst ForecastNews CoverageHigh Trading VolumeINSPInspire Medical Systems4.8505 of 5 stars$159.60+1.5%$226.70+42.0%-29.0%$4.75B$802.80M92.261,246News CoveragePositive NewsNARIInari Medical0.9868 of 5 stars$79.97flat$68.00-15.0%N/A$4.68B$493.63M-59.24800 Remove Ads Related Companies and Tools Related Companies GE HealthCare Technologies Competitors Koninklijke Philips Competitors Zimmer Biomet Competitors Solventum Competitors Penumbra Competitors Stevanato Group Competitors Glaukos Competitors Bausch + Lomb Competitors Inspire Medical Systems Competitors Inari Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SNN) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Smith & Nephew plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Smith & Nephew With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.